Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.09) by 44.44 percent. This is a 95.65 percent increase over losses of $(1.15) per share from the same period last year. The company reported quarterly sales of $78.048 million which beat the analyst consensus estimate of $74.036 million by 5.42 percent. This is a 42.00 percent increase over sales of $54.963 million the same period last year.